Regenerative medicine and stem cell therapies

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

56 papers

Active filtersClassification:Supporting

Showing 25-36 of total 56 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Optimization of a Canine Colon Organoid Platform for Modeling Intestinal Injury and Mesenchymal Stem Cell-Mediated Regeneration.

Park HJ; Lee HS; Lee Y; Yu JH; Yang JW; Ahn JS; Sung ES; Jang M; Seo Y; Kim HS

2026PubMedSupporting evidence

Magnetic nanoparticle formulations to activate TREK and Piezo mechanosensitive ion channels (MICA) for enhanced osteogenesis.

Kritika; Rotherham M; Du Y; Leerattanapetch K; Broomhall TJ; Roy I; El Haj AJ

Jan 1, 2026Regenerative biomaterials

2026PubMedSupporting evidence

Induced pluripotent stem cells from sporadic pulmonary veno-occlusive disease exhibit altered endothelial commitment and stress-related transcriptional programs.

Lian L; Daniels N; Wanner N; Comhair S; Poplawski GHD; Asosingh K; Lopez-Gonzalez R

Jan 1, 2026Frontiers in cell and developmental biology

2026PubMedSupporting evidence

Revisiting Pluripotency Acquisition: A Unified Framework for Reprogramming Strategies.

Datta A; Ohta K

Jan 1, 2026Development, growth & differentiation

2026PubMedSupporting evidence

cGMP-compliant large-scale manufacturing of human-induced pluripotent stem cells: current progress and challenges.

Lin X; Bui TV

Jan 1, 2026Cytotherapy

2026PubMedSupporting evidence

Generation of alveolar organoids from human induced pluripotent stem cells using a stirred-tank bioreactor.

Budeus B; Cremer L; Sevindik ZF; Klein D

Jan 1, 2026Frontiers in bioengineering and biotechnology

2026PubMedSupporting evidence

Generation of alveolar organoids from human induced pluripotent stem cells using a stirred-tank bioreactor.

Budeus B; Cremer L; Sevindik ZF; Klein D

Jan 1, 2026Frontiers in bioengineering and biotechnology

2026PubMedSupporting evidence

A scalable stem cell-derived erythroid cell system for the encapsulation and delivery of therapeutic enzymes: An in vitro proof-of-concept study.

Cheng X; Zhang B; Ling Y; Deng H; Yang Y; Xi J; Yang M; Gong W; Wang Y; Yue W; Li Y; Gao C

Jan 1, 2026The international journal of biochemistry & cell biology

2026PubMedSupporting evidence

Donor HLA-E*01:06 Confers Protection from Relapse and Improved Survival after T cell depleted Matched Unrelated Donor Haematopoietic Cell Transplantation.

Lucas JAM; Hewerdine S; Voiniciuc DF; Turner TR; Szydlo RM; Bloor A; Gibson B; Clark A; Roberts W; Amrolia PJ; Olavarria E; Potter V; Tholouli E; Byrne J; Medd P; Kinsella F; Snowden JA; Wynn R; Nicholson E; Patrick K; Richardson D; Khan AB; Klammer M; Potter M; Martin M; Furness C; Carpenter B; Saif MA; Lee J; Wilson M; Anthias C; Danby R; Robinson J; Marsh SGE; Mayor NP

Jan 1, 2026Transplantation and cellular therapy

2026PubMedSupporting evidence

The Journey of Endodontic Biomaterials - Navigating Scientific, Clinical, Patient and Regulatory Demands.

Widbiller M; Galler KM; Schmalz G

Jan 1, 2026Journal of endodontics

2024CrossrefSupporting evidence0 citations

Regenerative Medicine and Dentistry

Yin Xiao; Krasimir Vasilev; Yuelian Liu; Akon Higuchi

Oct 9, 2024Regenerative Medicine and Dentistry

2024CrossrefSupporting evidence3 citations

Designer cell therapy for tissue regeneration

Noyuri Zama; Satoshi Toda

Mar 15, 2024Inflammation and Regeneration